Seminars in arthritis and rheumatism, vol.50, pp.1387-1393, 2020 (SCI-Expanded)
Objective: Detailed analysis of hematological manifestations (HM) in systemic lupus erythematosus (SLE) are limited and their clinical impact on disease remain obscure. Here, we aimed to decipher factors associated with different hematological abnormalities in SLE patients and to assess their impact on disease related outcomes.